Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model.
BACKGROUND
Cancer growth, invasion and metastasis are highly related to tumor-associated neovasculature. The presence and progression of endothelial cells in cancer is chaotic, unorganized, and angiogenic vessels are less functional. Therefore, not all markers appearing on the chaotic endothelial cells are accessible if a drug is given through the vascular route. Identifying endothelial cell markers from functional cancer angiogenic vessels will indicate the accessibility and potential efficacy of vascular targeted therapies.


RESULTS
In order to quickly and effectively identify endothelial cell markers on the functional and accessible tumor vessels, we developed a novel technique by which tumor angiogenic vessels are labeled in vivo followed by Laser Capture Microdissection of microscopically isolated endothelial cells for genomic screening. Female C3H mice (N = 5) with established SCCVII tumors were treated with Rhodamine-RCA lectin by tail vein injection, and after fluorescence microscopy showed a successful vasculature staining, LCM was then performed on frozen section tissue using the PixCell II instrument with CapSure HS caps under the Rhodamine filter. By this approach, the fluorescent angiogenic endothelial cells were successfully picked up. As a result, the total RNA concentration increased from an average of 33.4 ng/ul +/- 24.3 (mean +/- S.D.) to 1913.4 ng/ul +/- 164. Relatively pure RNA was retrieved from both endothelial and epithelial cells as indicated by the 260/280 ratios (range 2.22-2.47). RT-PCR and gene electrophoresis successfully detected CD31 and Beta-Actin molecules with minimal Keratin 19 expression, which served as the negative control.


CONCLUSIONS
Our present study demonstrates that in vivo Rhodamine RCA angiogenic vessel labeling provided a practical approach to effectively guide functional endothelial cell isolation by laser capture microdissection with fluorescent microscopy, resulting in high quality RNA and pure samples of endothelial cells pooled for detecting genomic expression.
Hunter
Finie
F
Molecular Imaging Laboratory, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. finieh@hotmail.com
Xie
Jianwu
J
Trimble
Cameron
C
Bur
Monica
M
Li
King C P
KC
D000818:Animals; D001483:Base Sequence; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000098:blood supply* / Q000235:genetics / Q000473:pathology; D045744:Cell Line, Tumor; D002469:Cell Separation; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology; D005260:Female; D005456:Fluorescent Dyes; D007834:Lasers; D051379:Mice; D008809:Mice, Inbred C3H; D042282:Microdissection / Q000379:methods*; D008969:Molecular Sequence Data; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000473:pathology*; D037121:Plant Lectins; D012235:Rhodamines; D013194:Staining and Labeling
D005456:Fluorescent Dyes; D037121:Plant Lectins; D012235:Rhodamines; C017707:Ricinus communis agglutinin-1